BioRestorative Therapies, Inc.
BRTX
$1.08
-$0.01-0.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.80K | 303.30K | 25.00K | 43.30K | 233.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.80K | 303.30K | 25.00K | 43.30K | 233.60K |
| Cost of Revenue | 10.60K | 8.70K | 2.90K | 3.30K | 18.20K |
| Gross Profit | 1.20K | 294.60K | 22.10K | 40.00K | 215.40K |
| SG&A Expenses | 1.12M | 1.37M | 3.12M | 1.07M | 1.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.72M | 3.61M | 4.83M | 2.73M | 2.52M |
| Operating Income | -3.71M | -3.31M | -4.81M | -2.69M | -2.29M |
| Income Before Tax | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M |
| EBIT | -3.71M | -3.31M | -4.81M | -2.69M | -2.29M |
| EBITDA | -3.66M | -3.25M | -4.76M | -2.64M | -2.24M |
| EPS Basic | -0.33 | -0.30 | -0.64 | -0.20 | -0.13 |
| Normalized Basic EPS | -0.21 | -0.19 | -0.40 | 0.01 | -0.08 |
| EPS Diluted | -0.33 | -0.30 | -0.64 | -0.20 | -0.13 |
| Normalized Diluted EPS | -0.21 | -0.19 | -0.40 | 0.01 | -0.08 |
| Average Basic Shares Outstanding | 9.12M | 8.74M | 8.36M | 8.13M | 8.12M |
| Average Diluted Shares Outstanding | 9.12M | 8.74M | 8.36M | 8.13M | 8.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |